Newsletter
The Aducanumab Aftermath: The Patient

Archive-Tradeoffs

The Aducanumab Aftermath: The Patient

Desperate to slow her cognitive decline, one patient shares her hopes and concerns about the first new Alzheimer’s drug in nearly 20 years.This episode is part of a special weeklong…
June 23, 2021

The Aducanumab Aftermath: The Patient

Desperate to slow her cognitive decline, one patient shares her hopes and concerns about the first new Alzheimer’s drug in nearly 20 years.

This episode is part of a special weeklong series examining the potentially sweeping consequences this drug, known as aducanumab, could have on millions of patients’ lives and billions of dollars in health care spending.

Guest: Arthena Caston, Alzheimer’s patient and advocate

Explore the full series and additional resources: https://tradeoffs.org/aducanumab

Read a transcript of this episode: https://tradeoffs.org/2021/06/23/the-aducanumab-aftermath-the-patient/

Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletter

Support this type of journalism today, with a gift: https://tradeoffs.org/donate

Follow us on Twitter: https://twitter.com/tradeoffspod


See acast.com/privacy for privacy and opt-out information.

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

Buffer LinkedIn WhatsApp